Cogent Biosciences, Inc.
COGT
$39.16
$0.180.46%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 64.34% | -3.18% | -14.43% | -14.44% | -7.63% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -11.26% | -0.87% | -23.12% | 56.35% | -11.04% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 62.14% | -3.11% | -14.70% | -13.19% | -7.69% |
|
|
|||||
| Total Current Assets | 62.14% | -3.11% | -14.70% | -13.19% | -7.69% |
| Net Property, Plant & Equipment | -4.34% | -4.24% | -1.93% | -3.74% | -2.88% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -0.78% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Assets | 54.99% | -3.16% | -13.45% | -14.61% | -10.68% |
|
|
|||||
| Total Accounts Payable | -3.58% | 17.46% | 17.82% | -20.24% | 67.81% |
| Total Accrued Expenses | 11.22% | 17.53% | -60.58% | 131.99% | 23.41% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.90% | 2.92% | 2.94% | 2.96% | 3.05% |
| Total Finance Division Other Current Liabilities | 0.94% | 163.02% | 29.76% | 21.90% | 21.43% |
| Total Other Current Liabilities | 0.94% | 163.02% | 29.76% | 21.90% | 21.43% |
| Total Current Liabilities | 6.55% | 18.46% | -11.47% | 5.02% | 32.61% |
|
|
|||||
| Total Current Liabilities | 6.55% | 18.46% | -11.47% | 5.02% | 32.61% |
| Long-Term Debt | 0.68% | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -2.98% | -2.77% | -2.65% | -2.50% | -2.39% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 0.47% | 47,080.00% | -- | -- | -- |
| Total Liabilities | 3.08% | 84.84% | -9.51% | 3.25% | 22.30% |
|
|
|||||
| Common Stock & APIC | 21.69% | 0.96% | 3.72% | 1.01% | 1.48% |
| Retained Earnings | -8.05% | -7.89% | -8.38% | -8.58% | -9.80% |
| Treasury Stock & Other | 1,500.00% | -92.07% | -63.31% | -50.11% | 566.67% |
| Total Common Equity | 312.87% | -57.48% | -23.93% | -28.61% | -21.24% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00% | -0.23% | -2.20% | 0.00% | -3.08% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | -0.23% | -2.20% | 0.00% | -3.08% |
|
|
|||||
| Total Common Equity | 312.87% | -57.48% | -23.93% | -28.61% | -21.24% |
| Total Preferred Equity | 0.00% | -0.23% | -2.20% | 0.00% | -3.08% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 95.09% | -29.21% | -14.55% | -18.55% | -15.69% |
|
|
|||||